Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03765736 · ClinicalTrials.gov registry record
Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial
A clinical trial, sponsored by Academic and Community Cancer Research United.
- Terminated
- Registry status
- 199
- Enrollment target
NCT03765736: Clinical Trial study, sponsored by Academic and Community Cancer Research United.
NCT03765736 is a clinical trial that was terminated before completion, run by Academic and Community Cancer Research United. The registered enrollment target is 199 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03765736 was terminated before completion, sponsored by Academic and Community Cancer Research United.
- TERMINATED
- Registry status
- 199 participants
- Enrollment target
Study Summary
This trial screens patients with colon or rectal cancer that has spread to other places in the body (metastatic) or cannot be removed by surgery (unresectable) for genetic mutations for recommendation to a molecularly assigned therapy. Identifying gene mutations may help patients enroll onto target companion trials that target these mutations.
Primary Outcome
This is defined as a patient who received a trial recommendation per the COLOMATE companion trial recommendation form. Will be presented as a point estimate along with a 95% confidence interval (by Wald asymptotic confidence limit).
Interventions
- OTHER Genetic Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 2020-04-20 |
| Est. Completion | 2023-12-01 |
Why NCT03765736 stopped before completion
NCT03765736 is an observational study that tracks outcomes without assigning an intervention. The registered 199 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Genetic Testing is the first listed.
NCT03765736 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03765736 about?
NCT03765736 is a clinical study titled "Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial". This trial screens patients with colon or rectal cancer that has spread to other places in the body (metastatic) or cannot be removed by surgery (unresectable) for genetic mutations for recommendation to a molecularly assigned therapy. Identifying gene mutations may help patients enroll onto target ...
What is the current status of trial NCT03765736?
This trial is currently terminated. The enrollment target is 199 participants. The study started on 2020-04-20. Estimated completion is 2023-12-01.
What interventions are being tested in trial NCT03765736?
The interventions under investigation include: Genetic Testing (OTHER).
Who is sponsoring clinical trial NCT03765736?
This trial is sponsored by Academic and Community Cancer Research United, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04312126 · 199 participants
The Beneficial Effects of Naps on Motor Learning
- NCT04951622 · 199 participants · Phase 3
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- NCT06474533 · 199 participants
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI